<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HCFFA3D78609840F689D55C2E3005E1A0" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 1142 IH: To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-02-07</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 1142</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250207">February 7, 2025</action-date><action-desc><sponsor name-id="S001183">Mr. Schweikert</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.</official-title></form><legis-body id="H526E18B61A1C45E4A7D29F81EC8943E3" style="OLC"><section id="H26A433DD186B479DA00D6A5362FFEC2C" section-type="section-one"><enum>1.</enum><header>Establishment of drug adherence guidelines</header><text display-inline="no-display-inline">Title XVII of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/300u">42 U.S.C. 300u et seq.</external-xref>) is amended by inserting after section 1711 (<external-xref legal-doc="usc" parsable-cite="usc/42/300u-16">42 U.S.C. 300u–16</external-xref>) the following:</text><quoted-block style="OLC" id="H4353D243A53F487C99DE6B4315E4E1FA" display-inline="no-display-inline"><section id="H04E99CE5B4D3462F98AD984AA7468326"><enum>1712.</enum><header>Establishment of drug adherence guidelines</header><subsection id="HA603945860E8449581AD3C760FD6B156"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary shall establish drug adherence guidelines with the goal of achieving 90 percent adherence for all Medicare part B and D drugs.</text></subsection><subsection id="H189E3741B48041AD8F846EC272935DC5"><enum>(b)</enum><header>Contents</header><text>In establishing the guidelines under subsection (a), the Secretary shall—</text><paragraph id="H574A81FCD8F84ED5834A6B3937A8F0A1"><enum>(1)</enum><text>incorporate artificial intelligence and machine learning technologies; and</text></paragraph><paragraph id="H667D9B21741D4AD1B331550EEBBA6811"><enum>(2)</enum><text display-inline="yes-display-inline">to the maximum extent practicable, promote the use of generic and biosimilar drugs.</text></paragraph></subsection><subsection id="H829062CC84704728A53A5970396CE3D7"><enum>(c)</enum><header>Definitions</header><text display-inline="yes-display-inline">In this section:</text><paragraph id="HB0CB4CE6DB2E4E669FFC0D960CA57FAC"><enum>(1)</enum><header>Medicare part b drug</header><text>The term <quote>Medicare part B drug</quote> means a drug or biological product for which payment may be made under part B of title XVIII of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395j">42 U.S.C. 1395j et seq.</external-xref>). </text></paragraph><paragraph id="H67B3E19F99754906B422AE0F97BEB0AD"><enum>(2)</enum><header>Medicare part d drug</header><text display-inline="yes-display-inline">The term <quote>Medicare part D drug</quote> means a covered part D drug (as defined in section 1860D–2(e) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-102">42 U.S.C. 1395w–102(e)</external-xref>)).</text></paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block></section></legis-body></bill> 

